Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solar Lentigines Treatment With the Triple Combination Cream
NCT00975312Phase 2Completed
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Aug 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluocinolone acetonide + hydroquinone + tretinoin in solar lentigines (2 arms), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: Target lesion pigmentation becomes equal or slightly darker than the surrounding skin at 3 months. Started Aug 2008; status: completed.
02
Drugs
fluocinolone acetonide + hydroquinone + tretinoin
03
Conditions
solar lentigines
Beyond the preview
Go deeper on NCT00975312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975312.